Targeting Interleukin-6 Signaling in Clinic
- PMID: 30995492
- DOI: 10.1016/j.immuni.2019.03.026
Targeting Interleukin-6 Signaling in Clinic
Abstract
Interleukin-6 (IL-6) is a pleiotropic cytokine with roles in immunity, tissue regeneration, and metabolism. Rapid production of IL-6 contributes to host defense during infection and tissue injury, but excessive synthesis of IL-6 and dysregulation of IL-6 receptor signaling is involved in disease pathology. Therapeutic agents targeting the IL-6 axis are effective in rheumatoid arthritis, and applications are being extended to other settings of acute and chronic inflammation. Recent studies reveal that selective blockade of different modes of IL-6 receptor signaling has different outcomes on disease pathology, suggesting novel strategies for therapeutic intervention. However, some inflammatory diseases do not seem to respond to IL-6 blockade. Here, we review the current state of IL-6-targeting approaches in the clinic and discuss how to apply the growing understanding of the immunobiology of IL-6 to clinical decisions.
Keywords: IL-6; IL-6 receptor; acute; cancer; chronic; gp130; inflammation.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Interleukin-6: A Masterplayer in the Cytokine Network.Oncology. 2020;98(3):131-137. doi: 10.1159/000505099. Epub 2020 Jan 20. Oncology. 2020. PMID: 31958792 Review.
-
Interleukin-6: designing specific therapeutics for a complex cytokine.Nat Rev Drug Discov. 2018 Jun;17(6):395-412. doi: 10.1038/nrd.2018.45. Epub 2018 May 4. Nat Rev Drug Discov. 2018. PMID: 29725131 Review.
-
[IL-6 signal transduction and its physiological roles].Nihon Rinsho. 2012 Nov;70 Suppl 8:192-206. Nihon Rinsho. 2012. PMID: 23513837 Japanese. No abstract available.
-
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.J Clin Invest. 2011 Sep;121(9):3375-83. doi: 10.1172/JCI57158. Epub 2011 Sep 1. J Clin Invest. 2011. PMID: 21881215 Free PMC article. Review.
-
Interleukin-6 as a key player in systemic inflammation and joint destruction.Autoimmun Rev. 2009 Jun;8(7):538-42. doi: 10.1016/j.autrev.2009.01.012. Epub 2009 Feb 2. Autoimmun Rev. 2009. PMID: 19189867 Review.
Cited by
-
Cytokines and lymphocyte subsets are associated with disease severity of severe fever with thrombocytopenia syndrome.Virol J. 2024 Jun 3;21(1):126. doi: 10.1186/s12985-024-02403-0. Virol J. 2024. PMID: 38831352 Free PMC article.
-
The critical impacts of cytokine storms in respiratory disorders.Heliyon. 2024 Apr 17;10(9):e29769. doi: 10.1016/j.heliyon.2024.e29769. eCollection 2024 May 15. Heliyon. 2024. PMID: 38694122 Free PMC article. Review.
-
Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis.J Transl Med. 2024 Apr 30;22(1):402. doi: 10.1186/s12967-024-05205-8. J Transl Med. 2024. PMID: 38689325 Free PMC article. Review.
-
Protective effects of Jing-Si-herbal-tea in inflammatory cytokines-induced cell injury on normal human lung fibroblast via multiomic platform analysis.Tzu Chi Med J. 2024 Mar 26;36(2):152-165. doi: 10.4103/tcmj.tcmj_267_23. eCollection 2024 Apr-Jun. Tzu Chi Med J. 2024. PMID: 38645788 Free PMC article.
-
STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells.Cell Death Dis. 2024 Apr 13;15(4):265. doi: 10.1038/s41419-024-06638-1. Cell Death Dis. 2024. PMID: 38615022 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous